Depo-Provera Lawsuit — 2026 Status Guide

Depo-Provera (medroxyprogesterone acetate) is a birth control shot manufactured by Pfizer. Since 2024, thousands of women have filed lawsuits alleging Depo-Provera caused meningioma (a type of brain tumor). Here's the 2026 status of the Depo-Provera lawsuit.

What the Depo-Provera lawsuits allege

Plaintiffs allege that Depo-Provera and its generic form caused non-cancerous but often serious brain tumors called meningiomas. The lawsuits allege that Pfizer knew or should have known about the risk but did not adequately warn.

Depo-Provera MDL and class action status

• MDL 3140 — In re: Depo-Provera Products Liability Litigation was created in early 2024 in the Northern District of California
• By late 2025, over 3,000 individual lawsuits had been filed and consolidated
• Bellwether trials are expected to begin in 2026-2027
• A global class settlement is not yet finalized

When will Depo-Provera lawsuits be settled?

Based on similar MDLs (Bayer/Monsanto, Zantac), settlement negotiations typically begin after bellwether trials produce reference-point verdicts. Realistic Depo-Provera settlement timeline: 2027-2029. Individual plaintiffs may see resolutions sooner.

Am I eligible for a Depo-Provera lawsuit?

You may qualify to file an individual lawsuit if you:

• Received Depo-Provera injections
• Were diagnosed with meningioma (brain tumor)
• The diagnosis came after Depo-Provera use

How to join the Depo-Provera lawsuit

Unlike consumer class actions, mass tort MDLs like this one require you to file an individual lawsuit — not a class action claim. Contact a mass-tort attorney who handles Depo-Provera cases. Most work on contingency (no fee unless you recover).

Related class actions to watch

Beyond Depo-Provera, similar hormonal contraceptive class actions cover other products. Class Action Buddy tracks pharmaceutical class actions and mass torts alongside consumer settlements.